Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugs.

Trial Profile

The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugs.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Antihyperglycaemics; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LANTUSTITR
  • Sponsors Sanofi
  • Most Recent Events

    • 25 Aug 2011 Additional drug company added in associations field as reported by European Clinical Trials Database record.
    • 28 Jan 2009 Actual patient numbers (4) added as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Actual initiation date changed from May 2006 to Sep 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top